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INTRODUCTION
Lowering	the	threshold	for	statistical	
significance	in	medical	research	from	a	P	
value	of	.05	to	.005	was	recently	proposed	
to	reduce	misinterpretation	of	study	
results. 1,2 P	values	less	than	.05	but	
greater	than	.005	would	be	reclassified	as	
“suggestive”,	whereas	P	values	less	than	
.005	would	be	considered	significant.	
What	effect	this	proposal	would	have	on	
orthopaedic sports	medicine	literature	is	
currently	unclear.	We	evaluated	primary	
endpoints	in	randomized	clinical	trials	
(RCTs)	published	in	the	3	highest	ranked	
orthopaedic sports	medicine	journals,	as	
determined	by	Google	Scholar’s	H-5	index,	
to	determine	how	the	newly	proposed	
threshold	could	affect	the	interpretation	
of	previously	published	sports	medicine	
RCTs.
METHODS
We	searched	PubMed	from	January	01,	
2016	to	December	31,	2017	for	RCTs	
published	in	the	American	Journal	of	
Sports	Medicine,	Arthroscopy,	and	Knee	
Surgery,	Sports	Traumatology,	
Arthroscopy.	All	RCTs	were	screened	by	at	
least	2	authors.	We	extracted	P	value	data	
for	primary	endpoints,	since	RCTs	are	most	
often	powered	for	these	endpoints.	If	a	
study	had	multiple	primary	endpoints,	or	
evaluated	the	primary	endpoint	from	
multiple	domains,	all	P	values	for	these	
endpoints	were	include.	Data	were	
extracted	blinded	and	in	duplicate	fashion.	
Discrepancies	were	resolved	by	
consensus.	We	used	Google	Forms	for	
data	extraction	and	STATA	13.1	for	the	
data	analysis.
CONCLUSION
RESULTS
Our	final	sample	consisted	of	132	included	
studies	with	276	primary	endpoints	recorded.	Of	
the	endpoints	included	in	the	studies,	only	13.6%	
(18/132)	of	the	studies	have	endpoints	in	which	
all	P	values	are	below	the	new	threshold	of	.005.	
14.4%	(19/132)	of	the	studies	have	endpoints	in	
which	some	would	meet	the	new	P	value	
threshold	of	.005,	and	some	would	not	meet	this	
new	threshold	and	71.9%	(95/132)	of	the	studies	
have	no	endpoints	in	which	the	P	value(s)	was	
less	that	.005.	Within	the	160	studies,	we	
identified	 individual	endpoints	with	reported	P	
value	data.	1/%)	endpoints	had	a	P	value	less	
than	.05	and	193	(55%)	had	a	P value	greater	
than	.05.	Overall,	40.3%	(50/124)	of	the	
previously	statistically	significant	primary	
endpoints	were	less	than	.005,	while	59.7%	
(74/124)	would	be	reclassified	as	suggestive.	 The	
most	common	type	of	endpoints	were	outcome	
scores,	with	50%	(66/132)	of	the	studies	using	
this	method	of	assessment.	Surgery	was	the	
primary	intervention	type	for	49.2%	(65/132)	of	
the	included	trials.	The	majority	of	trials	did	not	
mention	any	funding	source	(56.8%	75/132).	The	
majority	of	included	trials,	(125/132),	had	
randomized	groups.
Of	statistically	significant	endpoints	RCTs	
published	in	the	3	highest	impact	
orthopaedic sports	medicine	journals,	
only	17%	(59/350)	would	maintain	their	
statistical	significance	with	a	P	value	
threshold	of	less	than	.005,	and	only	8%	of	
studies	would	maintain	their	overall	
significance	with	all	P	values	falling	below	
the	new	threshold.	A	.005	threshold	for	
significance	may	address	the	
shortcomings	of	P values,	such	as	
underpowered	RCTs3,	spurious	false	
positive	results4,	 and	P	hacking	(when	
researchers	analyze	data	multiple	ways	
until	a	significant	effect	is	found)	5.	
However,	as	our	results	indicate,	doing	so	
would	heavily	alter	the	significance	of	
orthopaedic sports	medicine	RCTs	and	this	
proposed	threshold	should	be	further	
evaluated,	and	cautiously	interpreted.	
